A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

NCT02347917 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesothelioma
Non-Small Cell Lung Cancer

Interventions

DRUG: BBI608
DRUG: Pemetrexed
DRUG: Cisplatin

Sponsor

Sumitomo Pharma Co., Ltd.